Stockhub

Ind-Swift Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

28 September 2022

  • curprev 00:3400:34, 28 September 2022 87.224.91.72 talk 1,099 bytes +1,099 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology,..."
Retrieved from "https://stockhub.co/research/Ind-Swift_Limited"